Pharmacological enhancement of autophagy induced in a hepatocellular carcinoma cell line by high-LET radiation

Anticancer Research

Volumn 30, Issue 2, 2010, Pages 303-310

  Anaïs, Altmeyer ^a   Jung, Alain C ^a   Ignat, Mihaela ^b   Benzina, Sami ^a   Denis, Jean Marc ^c   Gueulette, John ^c   Noël, Georges ^a   Mutterand, Didier ^c   Bischoff, Pierre ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b IRCAD   (France)

^c UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

Author keywords

Apoptosis; Autophagy; Hepatocellular carcinoma; High LET radiation; Oxaliplatin; PARP

Indexed keywords

HISTONE H2AX; N (5,6 DIHYDRO 6 OXO 2 PHENANTHRIDINYL) 2 DIMETHYLAMINOACETAMIDE; OXALIPLATIN; POLY(ADENOSINE DIPHOSPHATE RIBOSE);

APOPTOSIS; ARTICLE; AUTOPHAGY; CARCINOMA CELL; CELL DEATH; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DOUBLE STRANDED DNA BREAK; HUMAN; HUMAN CELL; IRRADIATION; LINEAR ENERGY TRANSFER; LIVER CELL CARCINOMA; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; AUTOPHAGY; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DNA BREAKS, DOUBLE-STRANDED; DNA REPAIR; HISTONES; HUMANS; LINEAR ENERGY TRANSFER; LIVER NEOPLASMS; NEUTRONS; ORGANOPLATINUM COMPOUNDS; POLY(ADP-RIBOSE) POLYMERASES;

EID: 77950533743     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Amaldi U and Kraft G: European developments in radiotherapy with beams of large radiobiological effectiveness. 2007. J Radiat Res 48(suppl): A27-A41, 2007.
2. Orecchia R, Krengli M, Jereczek-Fossa BA et al: Clinical and research validity of hadrontherapy with ion beams. Crit Rev Oncol Hematol 51: 81-90, 2004.
3. Zamboni WC. Concept and clinical evaluation of carrier-mediated anticancer agents. Oncologist 13: 248-260, 2008.
4. Milas L, Mason KA, Liao Z and Ang KK: Chemoradiotherapy: emerging treatment improvement strategies. Head & Neck 25: 152-167, 2003.
5. Oehler C, Dickinson DJ, Broggini-Tenzer M et al: Current concepts for the combined treatment modality of ionizing radiation with anticancer agents. Curr Pharm Des 13: 519-535, 2007.
6. Bischoff P, Altmeyer A and Dumont F: Radiosensitising agents for the radiotherapy of cancer: advances in traditional and hypoxia targeted radiosensitizers. Expert Op Ther Pat 19: 643-662, 2009.
7. Hao D, Ritter MA, Oliver et al: Platinum-based concurrent chemoradiotherapy for tumors of the head and neck and the esophagus. Sem Radiat Oncol 16: 10-19, 2009.
8. Faivre S, Chan D, Salinas R et al: DNA strand breaks and apoptosis induced by oxaliplatin in cancer cells. Biochem Pharmacol 66: 225-237, 2003.
9. Durdux C: Cisplatin and derivatives whh radiation therapy: for what clinical use? Cancer Radiother 8(Suppl 1): S88-S94, 2004.
10. Benzina S, Debomy F, Bergerat JP et al: The cytotoxicity of high-linear energy radiation is reinforced by oxaliplatin in human glioblastoma cells. Cancer Lett 254: 54-62, 2007.
11. Benzina S, Altmeyer A, Malek F et al: High-LET radiation combined with oxaliplatin induces autophagy in U-87 glioblastoma cells. Cancer Lett 264: 63-70, 2008.
12. Dawson LA: The evolving role of radiation therapy in hepatocellular carcinoma. Cancer Radiother 12: 96-101, 2008.
13. Garcia-Escudero V and Gargini R: Autophagy induction as an efficient strategy to eradicate tumors. Autophagy 4: 923-925, 2008.
14. Ratnam K and Low JA: Current development of clinical inhibitors of poly(ADP-ribose)polymerase in oncology. Clin Cancer Res 13: 1383-1388, 2007.
15. Riccardi C and Nicoletti I: Analysis of apoptosis by propidium iodide staining and flow cytometry. Nature Protoc 1: 1458-1461, 2006.
16. Daido S, Yamamoto A, Fujiwara K et al: Inhibition of the DNA-dependent protein kinase catalytic subunit radiosensitizes malignant glioma cells by inducing autophagy. Cancer Res 65: 4368-4375, 2005.
17. Kim KW, Hwang M, Moretti L et al: Autophagy up-regulation by inhibitors of caspase-3 and mTOR enhances radiotherapy in a mouse model of lung cancer. Autophagy 4: 659-668, 2008.
18. Gozuacik D and Kimchi A: Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23: 2891-2906, 2004.
19. Lefranc F, Facchini V and Kiss R: Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas. Oncologist 12: 1395-1403, 2007.
20. Abedin MJ, Wang D, McDonnell MA et al: Autophagy delays apoptotic death in breast cancer cells following DNA damage. Cell Death Diff 14: 500-510, 2007.
21. Gewirtz DA, Hilliker ML and Wilson EN: Promotion of autophagy as a mechanism of radiation sensitization of breast tumor cells. Radiother Oncol 62: 323-328, 2009.
22. Rieber M and Rieber MS: Sensitization to radiation-induced DNA damage accelerates loss of bcl-2 and increases apoptosis and autophagy. Cancer Biol Ther 7: 1561-1566, 2008.
23. Chiu S-J, Chao J-I, Lee Y-J et al: Regulation of gamma H2AX and securin contribute to apoptosis by oxaliplatin via a p38 mitogen-activated protein kinase-dependent pathway in human colorectal cancer cells. Toxicol Lett 179: 63-70, 2008.
24. Radford IR: DNA lesion complexity and induction of apoptosis by ionizing radiation. Int J Radiat Biol 78: 457-466, 2002.
25. Hada M and Georgakilas AG: Formation of clustered DNA damage after high-LET irradiation: a review. J Radiat Res 49: 203-210, 2008.
26. Yang YC, Chao KS, Lin CP et al: Oxaliplatin regulates DNA repair responding to ionizing radiation and enhances radiosensitivity of human cancers cells. Int J Gynecol Cancer 19: 782-786, 2009.
27. Lambert LA, Qiao N, Hunt KK et al: Autophagy: a novel mechanism of synergistic cytotoxicity between doxorubicin and roscovitine in a sarcoma model. Cancer Res 68: 7966-7974, 2008.
28. Bussink J, van der Kogel AJ and Kaanders JH: Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer. Lancet Oncol 9: 288-296, 2008.
29. Fujiwara K, Iwato E, Mills GB et al: AKT inhibition shows anticancer and radiosensitizing effects in malignant cells by inducing autophagy. Int J Oncol 31: 753-760, 2007.
30. Hino M, Wada S, Tajika Y et al: Heavy ion microbeam irradiation induces ultrastructural changes in isolated single fibers of skeletal muscle. Cell Struct Funct 32: 51-56, 2007.
31. Huang SH, Xiong M, Chen XP et al: PJ34, an inhibitor of PARP-1, suppresses cell growth and enhances the suppressive effects of cisplatin in liver cancer cells. Oncol Rep 20: 567-572, 2008.
32. Dumont F, Altmeyer A and Bischoff P: Radiosensitising agents for the radiotherapy of cancer: novel molecularly targeted approaches. Expert Op Ther Pat 19: 775-799, 2009.
33. Zois C and Koukourakis MI: Radiation-induced autophagy in normal and cancer cells: towards novel cytoprotection and radiosensibilization policies. Autophagy 5: 1-9, 2009.
34. Rixe O and Fojo T: Is cell death a critical end point for anticancer therapies or is cytostasis, sufficient. Clin Cancer Res 13: 7280-7287, 2007.